AAAAAA

   
Results: 1-17 |
Results: 17
STRESS AND IMMUNE-RESPONSES AFTER SURGICAL-TREATMENT FOR REGIONAL BREAST-CANCER
Authors: ANDERSEN BL FARRAR WB GOLDENKREUTZ D KUTZ LA MACCALLUM R COURTNEY ME GLASER R
Citation: Bl. Andersen et al., STRESS AND IMMUNE-RESPONSES AFTER SURGICAL-TREATMENT FOR REGIONAL BREAST-CANCER, Journal of the National Cancer Institute, 90(1), 1998, pp. 30-36
ESTROGEN-INDUCED KERATINOCYTE GROWTH-FACTOR MESSENGER-RNA EXPRESSION IN NORMAL AND CANCEROUS HUMAN BREAST CELLS
Authors: ZHANG Y SUGIMOTO Y KULP SK FARRAR WB BRUEGGEMEIER RW LIN YC
Citation: Y. Zhang et al., ESTROGEN-INDUCED KERATINOCYTE GROWTH-FACTOR MESSENGER-RNA EXPRESSION IN NORMAL AND CANCEROUS HUMAN BREAST CELLS, Oncology Reports, 5(3), 1998, pp. 577-583
BIODISTRIBUTION AND LOCALIZATION OF RADIOLABELED NR-LU-10 FAB FRAGMENT IN HUMAN BREAST-CANCER XENOGRAFTS
Authors: BURAK WE DEPALATIS L NINES R HITCHCOCK C HINKLE G HOUCHENS D FARRAR WB
Citation: We. Burak et al., BIODISTRIBUTION AND LOCALIZATION OF RADIOLABELED NR-LU-10 FAB FRAGMENT IN HUMAN BREAST-CANCER XENOGRAFTS, Nuclear medicine and biology, 25(7), 1998, pp. 633-637
KERATINOCYTE GROWTH-FACTOR (KGF) INDUCES AROMATASE-ACTIVITY IN CULTURED MCF-7 HUMAN BREAST-CANCER CELLS
Authors: ZHANG Y KULP SK SUGIMOTO Y FARRAR WB BRUEGGEMEIER RW LIN YC
Citation: Y. Zhang et al., KERATINOCYTE GROWTH-FACTOR (KGF) INDUCES AROMATASE-ACTIVITY IN CULTURED MCF-7 HUMAN BREAST-CANCER CELLS, Anticancer research, 18(4A), 1998, pp. 2541-2546
ANDROGENS INFLUENCE ESTROGEN-INDUCED RESPONSES IN HUMAN BREAST-CARCINOMA CELLS THROUGH CYTOCHROME-P450 AROMATASE
Authors: BURAK WE QUINN AL FARRAR WB BRUEGGEMEIER RW
Citation: We. Burak et al., ANDROGENS INFLUENCE ESTROGEN-INDUCED RESPONSES IN HUMAN BREAST-CARCINOMA CELLS THROUGH CYTOCHROME-P450 AROMATASE, Breast cancer research and treatment, 44(1), 1997, pp. 57-64
SEROMA FORMATION FOLLOWING AXILLARY DISSECTION FOR BREAST-CANCER - RISK-FACTORS AND LACK OF INFLUENCE OF BOVINE THROMBIN
Authors: BURAK WE GOODMAN PS YOUNG DC FARRAR WB
Citation: We. Burak et al., SEROMA FORMATION FOLLOWING AXILLARY DISSECTION FOR BREAST-CANCER - RISK-FACTORS AND LACK OF INFLUENCE OF BOVINE THROMBIN, Journal of surgical oncology, 64(1), 1997, pp. 27-31
CHROMOSOMAL AND IMMUNOHISTOCHEMICAL LOCALIZATION OF HUMAN FGF-8
Authors: SUGIMOTO Y CHANG WY KULP SK FARRAR WB BRUEGGEMEIER RW LIN YC
Citation: Y. Sugimoto et al., CHROMOSOMAL AND IMMUNOHISTOCHEMICAL LOCALIZATION OF HUMAN FGF-8, Molecular biology of the cell, 7, 1996, pp. 1077-1077
NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND BREAST-CANCER
Authors: HARRIS RE NAMBOODIRI KK FARRAR WB
Citation: Re. Harris et al., NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND BREAST-CANCER, Epidemiology, 7(2), 1996, pp. 203-205
GOSSYPOL (GP) STIMULATES TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) GENE-EXPRESSION IN HUMAN BREAST-CANCER CELL-LINE
Authors: ZHENG J SHIDAIFAT F ZHANG Y SUGIMOTO Y MULLA Z CANATAN H KULP SK FARRAR WB BRUEGGEMEIER RW LIN YC
Citation: J. Zheng et al., GOSSYPOL (GP) STIMULATES TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) GENE-EXPRESSION IN HUMAN BREAST-CANCER CELL-LINE, The FASEB journal, 10(3), 1996, pp. 4374-4374
EFFECT OF RECOMBINANT HUMAN KERATINOCYTE GROWTH-FACTOR (KGF) ON AROMATASE-ACTIVITY IN HUMAN BREAST-CANCER CELL
Authors: ZHANG Y ZHENG J SUGIMOTO Y SHIDAIFAT F KULP SK FARRAR WB BRUEGGEMEIER RW LIN YC
Citation: Y. Zhang et al., EFFECT OF RECOMBINANT HUMAN KERATINOCYTE GROWTH-FACTOR (KGF) ON AROMATASE-ACTIVITY IN HUMAN BREAST-CANCER CELL, The FASEB journal, 10(3), 1996, pp. 4376-4376
ADJUVANT CMFVP VERSUS ADJUVANT CMFVP PLUS OVARIECTOMY FOR PREMENOPAUSAL, NODE-POSITIVE, AND ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER PATIENTS - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: RIVKIN SE GREEN S OSULLIVAN J CRUZ AB ABELOFF MD JEWELL WR COSTANZI JJ FARRAR WB OSBORNE CK
Citation: Se. Rivkin et al., ADJUVANT CMFVP VERSUS ADJUVANT CMFVP PLUS OVARIECTOMY FOR PREMENOPAUSAL, NODE-POSITIVE, AND ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER PATIENTS - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 14(1), 1996, pp. 46-51
HORMONE REPLACEMENT THERAPY AND BREAST-CANCER RISK
Authors: HARRIS RE NAMBOODIRI KK FARRAR WB SOLANO SM WYNDER EL
Citation: Re. Harris et al., HORMONE REPLACEMENT THERAPY AND BREAST-CANCER RISK, JAMA, the journal of the American Medical Association, 275(15), 1996, pp. 1158-1159
EPIDEMIOLOGIC-STUDY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND BREAST-CANCER
Authors: HARRIS RE NAMBOODIRI KK FARRAR WB
Citation: Re. Harris et al., EPIDEMIOLOGIC-STUDY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND BREAST-CANCER, Oncology Reports, 2(4), 1995, pp. 591-592
ANTIPROLIFERATIVE EFFECT OF GOSSYPOL-CONTAINING MILK ON PRIMARY CULTURED HUMAN BREAST-CANCER CELLS
Authors: MULLA Z SHIDAIFAT F ZHENG J ZHANG Y KULP S BRUEGGEMEIER RW FARRAR WB LIN YC
Citation: Z. Mulla et al., ANTIPROLIFERATIVE EFFECT OF GOSSYPOL-CONTAINING MILK ON PRIMARY CULTURED HUMAN BREAST-CANCER CELLS, Biology of reproduction, 52, 1995, pp. 172-172
THE NATURAL-HISTORY OF BREAST-CANCER WITH MORE THAN 10 POSITIVE NODES
Authors: WALKER MJ OSBORNE MD YOUNG DC SCHNEEBAUM S LAVALLE GJ FARRAR WB
Citation: Mj. Walker et al., THE NATURAL-HISTORY OF BREAST-CANCER WITH MORE THAN 10 POSITIVE NODES, The American journal of surgery, 169(6), 1995, pp. 575-579
ADJUVANT CMFVP VERSUS TAMOXIFEN VERSUS CONCURRENT CMFVP AND TAMOXIFENFOR POSTMENOPAUSAL, NODE-POSITIVE, AND ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER PATIENTS - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: RIVKIN SE GREEN S METCH B CRUZ AB ABELOFF MD JEWELL WR COSTANZI JJ FARRAR WB MINTON JP OSBORNE CK
Citation: Se. Rivkin et al., ADJUVANT CMFVP VERSUS TAMOXIFEN VERSUS CONCURRENT CMFVP AND TAMOXIFENFOR POSTMENOPAUSAL, NODE-POSITIVE, AND ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER PATIENTS - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 12(10), 1994, pp. 2078-2085
THE REGIONAL TREATMENT OF LIVER METASTASES FROM BREAST-CANCER
Authors: SCHNEEBAUM S WALKER MJ YOUNG D FARRAR WB MINTON JP
Citation: S. Schneebaum et al., THE REGIONAL TREATMENT OF LIVER METASTASES FROM BREAST-CANCER, Journal of surgical oncology, 55(1), 1994, pp. 26-31
Risultati: 1-17 |